The Department of Pharmaceuticals (DoP) has invited applications for the Promotion of Research and Innovation in Pharma MedTech sector (PRIP) scheme. The initiative aims to transform the Indian Pharma MedTech sector from cost-based to innovation-based growth by strengthening the research infrastructure in the country.

With a total financial outlay of INR 5,000 crore, the PRIP scheme will allocate INR 700 crore to establish Centers of Excellence (CoEs) at seven National Institutes of Pharmaceutical Education & Research (NIPERs), and INR 4,200 crore to strengthen the country’s R&D ecosystem.

The scheme will prioritise six key research areas: new chemical entity, new biological entity, and phyto-pharmaceuticals, complex generics and biosimilars, precision medicine (targeted innovative therapeutics), medical devices, orphan drugs and drug development for antimicrobial resistance (AMR).

It will support both Indian companies and subsidiaries of multinational firms incorporated in India, with each entity eligible for up to three projects. Funding will vary by category, ranging from 35 percent of project costs (up to INR 125 crore) for large-scale projects to INR 1 crore per project for smaller initiatives.

The deadline to register on the PRIP Portal is November 3, 2025, while the deadline for application submission is November 10, 2025.